Alnylam stock drops 2.6% premarket on preliminary results for rare disease therapy https://t.co/SsAoDjMw3l
— Marisa Peer (@PeerMarisa) September 27, 2018
from Twitter https://twitter.com/PeerMarisa
September 27, 2018 at 03:02AM
Thursday, September 27, 2018
Alnylam stock drops 2.6% premarket on preliminary results for rare disease therapy https://t.co/SsAoDjMw3l
from Twitter https://twitter.com/PeerMarisa
September 27, 2018 at 03:02AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment